These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25572763)

  • 1. Metabolic syndrome in first degree relatives of patients with type 2 diabetes: Incidence and risk factors.
    Janghorbani M; Amini M
    Diabetes Metab Syndr; 2011; 5(4):201-6. PubMed ID: 25572763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Metab Res Rev; 2009 Nov; 25(8):748-55. PubMed ID: 19862775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of glucose intolerance in first-degree relatives of patients with type 2 diabetes.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2010 Jun; 88(3):295-301. PubMed ID: 20167387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study.
    Janghorbani M; Amini M
    Ann Nutr Metab; 2016; 68(1):19-25. PubMed ID: 26559166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
    Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of the metabolic syndrome in IGT subjects in a lifestyle intervention: results from the SLIM study.
    den Boer AT; Herraets IJ; Stegen J; Roumen C; Corpeleijn E; Schaper NC; Feskens E; Blaak EE
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1147-53. PubMed ID: 23462149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of metabolic syndrome and its risk factors among type 2 diabetes clinic attenders in Isfahan, Iran.
    Janghorbani M; Amini M
    Endokrynol Pol; 2012; 63(5):372-80. PubMed ID: 23115071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study.
    Janghorbani M; Amini M
    Rev Diabet Stud; 2011; 8(4):490-8. PubMed ID: 22580730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors.
    Tamayo T; Schipf S; Meisinger C; Schunk M; Maier W; Herder C; Roden M; Nauck M; Peters A; Völzke H; Rathmann W
    PLoS One; 2014; 9(11):e113154. PubMed ID: 25402347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
    Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
    Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
    Madhu SV; Muduli SK; Avasthi R
    Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
    Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
    J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Androgens and Sex Hormone-Binding Globulin in Women and Risk of Metabolic Syndrome and Type 2 Diabetes.
    Fenske B; Kische H; Gross S; Wallaschofski H; Völzke H; Dörr M; Nauck M; Keevil BG; Brabant G; Haring R
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4595-603. PubMed ID: 26445113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction.
    Janghorbani M; Almasi SZ; Amini M
    Acta Diabetol; 2015 Aug; 52(4):781-8. PubMed ID: 25572334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study.
    Magliano DJ; Barr EL; Zimmet PZ; Cameron AJ; Dunstan DW; Colagiuri S; Jolley D; Owen N; Phillips P; Tapp RJ; Welborn TA; Shaw JE
    Diabetes Care; 2008 Feb; 31(2):267-72. PubMed ID: 17989310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
    Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
    Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study.
    Cameron AJ; Magliano DJ; Zimmet PZ; Welborn TA; Colagiuri S; Tonkin AM; Shaw JE
    J Intern Med; 2008 Aug; 264(2):177-86. PubMed ID: 18298479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.